SBCWW
SBC Medical Group Holdings Incorporated
NASDAQ · Industrials · Consulting Services · US
$0.32
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 175.2M | 173.6M | 205.4M | 193.5M | 174.2M |
| Cost of Revenue | 49.3M | 46.3M | 49.4M | 56.2M | 82.2M |
| Gross Profit | 125.9M | 127.3M | 156.1M | 137.3M | 92.0M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 44.8M | 59.8M | 70.7M | 66.2M | 70.1M |
| General & Admin Expense | 45.9M | 59.8M | 70.7M | 66.2M | 63.5M |
| Selling & Marketing Expense | (1.1M) | — | — | — | 6.6M |
| Other Expenses | 15.6M | — | 15.1M | 409.0K | 1.8M |
| Total Operating Expenses | 60.5M | 59.8M | 85.7M | 66.6M | 71.9M |
| Cost and Expenses | 109.8M | 106.1M | 135.1M | 122.9M | 154.0M |
| Operating Income (EBIT) | 65.4M | 67.5M | 70.3M | 70.7M | 20.1M |
| Non-Operating | |||||
| Interest Income | 250.0K | 198.3K | 19.9K | 86.7K | 440.9K |
| Interest Expense | 348.2K | 160.6K | 28.3K | 45.3K | — |
| Net Interest Income | (98.2K) | 37.7K | (8.4K) | 41.5K | 440.9K |
| Other Non-Op Income/Expense | 9.5M | 14.6M | 3.2M | 2.9M | 3.6M |
| Non-Operating Income (excl Interest) | (9.9M) | (14.7M) | (3.2M) | (3.0M) | (251.2K) |
| EBT (Pre-Tax Income) | 74.9M | 82.1M | 73.5M | 73.6M | 23.7M |
| Income Tax Expense | 25.3M | 31.0M | 26.8M | 35.0M | 18.1M |
| Bottom Line | |||||
| Net Income | 49.0M | 51.0M | 46.6M | 39.4M | 6.3M |
| Earnings from Cont. Ops | 49.6M | 51.0M | 46.7M | 38.6M | 5.6M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 49.0M | 51.0M | 46.6M | 39.4M | 6.3M |
| Per Share | |||||
| Basic EPS | $0.47 | $0.50 | $0.48 | $0.42 | $0.79 |
| Diluted EPS | $0.47 | $0.50 | $0.48 | $0.42 | $0.79 |
| Revenue Per Share | $1.71 | $1.69 | $2.13 | $2.05 | $21.91 |
| Shares | |||||
| Basic Shares Outstanding | 102.6M | 103.0M | 96.6M | 94.2M | 7.9M |
| Diluted Shares Outstanding | 102.6M | 103.0M | 96.6M | 94.2M | 7.9M |
| Profitability Metrics | |||||
| EBITDA | 77.4M | 84.9M | 77.3M | 85.9M | 26.3M |
| D&A | 2.1M | 2.7M | 3.8M | 12.2M | 5.9M |
| EBIT | 75.3M | 82.2M | 73.5M | 73.6M | 20.4M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026